Xolair and Definity drug interactions - a phase IV clinical study of FDA data
We study 68,439 people who take Xolair or Definity. There is no drug interaction reported.
The phase IV clinical study analyzes what interactions people who take Xolair and Definity have. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Xolair?
Xolair has active ingredients of omalizumab. It is often used in asthma. eHealthMe is studying from 64,588 Xolair users for its effectiveness, alternative drugs and more.
What is Definity?
Definity has active ingredients of perflutren. eHealthMe is studying from 3,851 Definity users for its effectiveness, alternative drugs and more.
Do you take Xolair and Definity?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of the 2 drugs:
How the study uses the data?
The study uses data from the FDA. It is based on omalizumab and perflutren (the active ingredients of Xolair and Definity, respectively), and Xolair and Definity (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Xolair and Definity.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Pamine and Enlarged Heart - 2 seconds ago
- Fludarabine Phosphate and Pleural Effusion - 10 seconds ago
- Aciphex and Jaw Cyst - 14 seconds ago
- Estradiol and Zopiclone drug interaction - 24 seconds ago
- Perjeta and Paraesthesia Oral - 28 seconds ago
- Pepcid Ac and Bumetanide drug interaction - 36 seconds ago
- Haloperidol Decanoate and Erection Problems - 38 seconds ago
- Senna and Mebeverine Hydrochloride drug interaction - 39 seconds ago
- Artane and Tardive Dyskinesia - 43 seconds ago
- Valchlor and Musculoskeletal Stiffness - 49 seconds ago